Novel tricyclic compounds treat depression and anxiety, indicating potential for substance abuse management and headache relief.
Provided herein are novel tricyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse and headaches, and processes for preparing such compounds.
No takes yet. Share an insight, caveat, or question.
Sabnis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: